However, a clinical, randomized, double-blind, placebo-controlled study with selective MMP-9 and MMP-12 inhibitor, AZD1236, did not yield any significant effect in reducing symptoms associated with moderate /severe COPD [138]. The gene discussed is MMP9; the disease is chronic obstructive pulmonary disease.